Lichen International (LICN) adopts 2025 Equity Incentive Plan, Form 6-K

Lichen International Limited reported that its Board of Directors approved and adopted a new 2025 Equity Incentive Plan, effective October 30, 2025.

Accepted by SEC EDGAR 11/07/2025 - 04:05 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Lichen International Limited reported that its Board of Directors approved and adopted a new 2025 Equity Incentive Plan, effective October 30, 2025. The plan is included as Exhibit 99.1 to the company’s Form 6-K.

The filing is an administrative update that adds the full text of the equity plan for reference. The report was signed by Chief Executive Officer Ya Li on November 7, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2025

Commission File Number: 001-41493

Lichen International Limited

15th Floor, Xingang Square

Hubin North Road, Siming District,

Xiamen City, Fujian Province

People’s Republic of China 361013

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒      Form 40-F ☐

On October 30, 2025, the Board of Directors of Lichen International Limited approved and adopted an equity incentive plan (the “2025 Equity Incentive Plan”), which became effective on October 30, 2025. Attached as Exhibit 99.1 to this Form 6-K is the 2025 Equity Incentive Plan.

EXHIBIT INDEX

Exhibit No.		Description
99.1		Lichen International Limited 2025 Equity Incentive Plan

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Lichen International Limited
Date: November 7, 2025	By:	/s/ Ya Li
	Name:	Ya Li
	Title:	Chief Executive Officer

2